Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 2/20 | 0.54 |
| ▸ | GSR | P00390 | 2/20 | 0.54 |
| ▸ | GRM8 | O00222 | 2/20 | 0.54 |
| ▸ | GRM6 | O15303 | 2/20 | 0.54 |
| ▸ | GRM7 | Q14831 | 2/20 | 0.54 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.54 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.54 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.54 |
| ▸ | GRM5 | P41594 | 1/20 | 0.54 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.54 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.54 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.54 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.54 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.54 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.54 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6267781 | 1.00 | SLC1A1 (0.54) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL2994699 | 1.00 | SLC1A1 (0.54) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL7717181 | 1.00 | SLC1A1 (0.54) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL3918242 | 1.00 | SLC1A1 (0.54) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL3430330 | 1.00 | SLC1A1 (0.54) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL27742505 | 0.98 | SLC1A1 (0.52) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL27976398 | 0.98 | SLC1A1 (0.52) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL5604914 | 0.98 | SLC1A1 (0.52) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL9857204 | 0.98 | SLC1A1 (0.52) | SLC1A1GSRGRM8GRM6GRM7 | |
| SCHEMBL27516513 | 0.98 | SLC1A1 (0.52) | SLC1A1GSRGRM8GRM6GRM7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117665155-A | Gastric cancer blood metabolism biomarker and screening method | 浙江省肿瘤医院 | 2024-03-08 | — | — | CN | claimed |
| WO-2023240022-A2 | CONJUGATE FOR TARGETING CENTRAL NERVOUS SYSTEM | SUNTEC MEDICAL, INC. (US) | 2023-12-14 | — | — | WO | claimed |
| CN-121324559-A | Application of metabonomics marker combination in preparation of product for identifying benign and malignant pulmonary glass nodule | 中国人民解放军总医院第八医学中心 | 2026-01-13 | — | — | CN | disclosed |
| CN-111868260-B | Methods and materials for assessing and treating cancer | 约翰斯霍普金斯大学 | 2025-02-21 | — | — | CN | disclosed |
| CN-117740961-A | Compound analysis method of liquorice and liquorice probiotics fermentation preparation | 北京中医药大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-117665155-A | Gastric cancer blood metabolism biomarker and screening method | 浙江省肿瘤医院 | 2024-03-08 | — | — | CN | disclosed |
| US-20220411448-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | Floratek Pharma SA (CH) | 2022-12-29 | — | — | US | disclosed |
| CN-115474671-A | Low-salt dried meat slices with low nitrite residues and preparation method | 江苏众阳食品有限公司 | 2022-12-16 | — | — | CN | disclosed |
| CN-113308122-A | Degradable protein plastic and preparation method thereof | 清华大学 | 2021-08-27 | — | — | CN | disclosed |
| CN-113163836-A | Compositions and methods for promoting host defense and stimulating, expanding and/or resetting T cell banks | 进化生物系统股份有限公司 | 2021-07-23 | — | — | CN | disclosed |
| WO-2021053205-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | FLORATEK PHARMA AG (CH) | 2021-03-25 | — | — | WO | disclosed |
| US-7081346-B2 | Method of screening binding of a compound to a receptor | MARQUETTE UNIVERSITY (US) | 2006-07-25 | — | — | US | disclosed |
| CN-1711910-A | Production of gourmet powder | UNIV JIANGNAN (CN) | 2005-12-28 | — | — | CN | disclosed |
| WO-2005058293-A1 | USE OF MEMANTINE FOR THE TREATMENT OF PROLIFERATIVE RETINAL DISEASES | ALLERGAN, INC. (US) | 2005-06-30 | — | — | WO | disclosed |
| WO-2004037281-A1 | METHODS FOR NEUROPROTECTION | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2004-05-06 | — | — | WO | disclosed |
| US-20030215959-A1 | Method of screening binding of a compound to a receptor | MARQUETTE UNIVERSITY | 2003-11-20 | — | — | US | disclosed |
| EP-0410881-B1 | Semisynthetic ganglioside analogues | FIDIA SPA (IT) | 1997-09-17 | — | — | EP | disclosed |
| WO-1994017198-A1 | ENZYMATIC FLUOROMETRIC ASSAY FOR ADENYLATE CYCLASE | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1994-08-04 | — | — | WO | disclosed |
| US-4766071-A | USING ALKANOLS AND ALKANALS AND ENZYME OBTAINED BY LYSIS OF CELL SUSPENSION | HENKEL KOMMANDITGESELLSHAFT AUF AKTIEN (DE) | 1988-08-23 | — | — | US | disclosed |
| EP-0110049-A2 | Mixed seasoning | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1984-06-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030215959-A1 | Method of screening binding of a compound to a receptor | FSHR, GRB7, GPR174 | SLC1A1 1776/4885GSR 2206/4885GRM8 24/4885 |
| US-20220411448-A1 | CHROMENE-4-ONE DERIVATIVES AS BRAIN-DERIVED NEUROTROPHIC FACTOR (BDNF) MIMETICS | BDNF, NTRK2, NGF | SLC1A1 1480/4885GSR 260/4885GRM8 630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.